Active	Status	Sponsor type	Region	Phase	Filter
1 Active 0 Inactive 1 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
BA9101 (aflibercept biosimilar) / Luye Group, Ocumension Therap
NCT04572698: A Study to Compare LY09004 and Eylea in the Treatment of Wet Age-related Macular Degeneration（wAMD）	Not yet recruiting	3	416	NA	LY09004, Recombinant Human Vascular Endothelial Growth Factor Receptor Antibody Fusion Protein Eye Injection, Eylea	Luye Pharma Group Ltd., Shan Dong Boan Biotechnology Co., Ltd(Co-sponsor)	Age Related Macular Degeneration	06/23	12/23